FDA's continues fraudulent H1N1 enforcement
This article was originally published in The Tan Sheet
Executive Summary
FDA continues its enforcement efforts against firms marketing products claiming to treat or prevent the H1N1 flu virus, with three new company warning letters posted to the agency Web site April 20 (1"The Tan Sheet" April 12, 2010). The warnings to three separate firms include an April 13 letter to Super Body Care, an April 13 letter to E-holistic Health and a Nov. 4 letter to Silver Soft Skin asking the firms to contact the agency with a corrective action plan to address the issues the agency identified. In each letter, the agency states that the products "have not been approved, cleared, or otherwise authorized by FDA for use in the diagnosis, mitigation, prevention, treatment or cure of the H1N1 Flu Virus." To date, FDA sent a total of 88 warning letters related to 162 H1N1 products